TONIX PHARMACEUTICALS HOLDING CORP. Payments for Repurchase of Common Stock
Shares the company repurchased and the cash it paid, as filed in its 10-Q and 10-K XBRL (statement of shareholders' equity and cash flow statement).
- TONIX PHARMACEUTICALS HOLDING CORP. payments for repurchase of common stock for the quarter ending 2025-12-31 was $7.81M.
- TONIX PHARMACEUTICALS HOLDING CORP. payments for repurchase of common stock for the quarter ending 2025-09-30 was $0.00.
- TONIX PHARMACEUTICALS HOLDING CORP. payments for repurchase of common stock for the quarter ending 2025-06-30 was $2.90M.
- TONIX PHARMACEUTICALS HOLDING CORP. payments for repurchase of common stock for the quarter ending 2025-03-31 was $3.05M.
- TONIX PHARMACEUTICALS HOLDING CORP. payments for repurchase of common stock for fiscal 2025 was $13.76M.
- TONIX PHARMACEUTICALS HOLDING CORP. payments for repurchase of common stock for fiscal 2023 was $13.96M.
| Period end | Payments for Repurchase of Common Stock 3 month | Payments for Repurchase of Common Stock 12 month |
|---|---|---|
| 2025-12-31 | $7.81M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $13.76M 10-K · filed 2026-03-12 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | |
| 2025-06-30 | $2.90M 10-Q · filed 2026-08-10 | |
| 2025-03-31 | $3.05M 10-Q · filed 2026-05-11 | |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-18 | $13.96M 10-K · filed 2025-03-18 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-16 | |
| 2023-03-31 | $13.96M 10-Q · filed 2024-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |